Searched over 200M research papers
10 papers analyzed
These studies suggest angiotensin 2 plays a crucial role in blood pressure regulation, cardiovascular function, and tissue remodeling, with potential therapeutic applications in hypertension, cardiovascular diseases, and kidney diseases.
20 papers analyzed
Angiotensin II (Ang II) is a critical peptide in the renin-angiotensin system (RAS), primarily known for its potent vasopressor effects, which means it can increase blood pressure by causing blood vessels to constrict. This action is mainly mediated through the Ang II type 1 receptor (AT1R) . The AT1R is responsible for several physiological responses, including vasoconstriction, stimulation of renal tubular sodium reabsorption, and hormonal secretion, all of which contribute to the regulation of blood pressure .
In contrast to AT1R, the Ang II type 2 receptor (AT2R) has been shown to counteract many of the effects mediated by AT1R. AT2R is involved in vasodilation, which is the widening of blood vessels, thereby reducing blood pressure. This receptor achieves its effects by stimulating the production of bradykinin, which in turn activates the nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) system, leading to vasodilation . Studies have demonstrated that overexpression of AT2R in vascular smooth muscle cells can significantly enhance this vasodilatory effect, suggesting a protective role in blood pressure regulation .
Angiotensin-converting enzyme 2 (ACE2) plays a crucial role in modulating the effects of Ang II. ACE2 converts Ang II into Angiotensin 1-7 (Ang-(1-7)), a peptide with vasodilatory properties that counterbalance the vasoconstrictive actions of Ang II . This conversion is essential for maintaining cardiovascular health, as it helps to mitigate the harmful effects of elevated Ang II levels, such as hypertension and cardiac hypertrophy . ACE2's protective role extends to various cardiovascular and renal diseases, where its deficiency can lead to increased tissue inflammation and damage .
Under pathological conditions, the expression of AT2R can increase, particularly in tissues undergoing remodeling or inflammation, such as in failing hearts or after vascular injury. In these scenarios, AT2R helps to inhibit cell proliferation and promote cell differentiation, thereby reducing tissue remodeling and inflammation . This receptor also plays a role in promoting programmed cell death (apoptosis) in certain contexts, further contributing to its protective effects in cardiovascular and renal diseases.
The dual roles of Ang II through its receptors, AT1R and AT2R, present significant therapeutic opportunities. While AT1R antagonists are commonly used to treat hypertension and related cardiovascular conditions, enhancing AT2R activity or ACE2 levels could offer additional benefits. For instance, selective stimulation of AT2R in the presence of AT1R antagonists may provide a more comprehensive approach to controlling blood pressure and protecting against cardiovascular damage . Similarly, therapies aimed at increasing ACE2 activity could help in reducing hypertension, atherosclerosis, and renal damage .
Angiotensin II is a pivotal component of the renin-angiotensin system, with significant roles in regulating blood pressure and cardiovascular function. Its effects are mediated through two main receptors, AT1R and AT2R, which have opposing actions. While AT1R promotes vasoconstriction and increases blood pressure, AT2R facilitates vasodilation and offers protective effects against cardiovascular and renal diseases. ACE2 further modulates these effects by converting Ang II into the vasodilatory peptide Ang-(1-7). Understanding these mechanisms opens up potential therapeutic avenues for treating hypertension and other related conditions.
Most relevant research papers on this topic